Listen to this articleBelow is our recent interview with Gary Higginson, CEO of SpinRise Technologies:
Q: How would you describe SpinRise Technologies in your own words?
A: Our company uses data to improve the treatment outcomes of children diagnosed with autism. Studies have shown that the best outcomes for children diagnosed with autism can be achieved through early, intensive intervention. Such intervention can also reduce the lifetime cost of services by two-thirds. SpinRise Technologies is developing tools to accelerate the process of helping autistic children reach their full potential.
Q: What is you mission?
A: The standard of care for children diagnosed with autism is Applied Behavioral Analysis. The standard of care for these kids is called Applied Behavioral Analysis. ABA relies heavily on data, but we’re currently missing about 60% of the data we need to do it well. We’ve developed a platform that combines narrative, video, and biometric data to give autism treatment professionals all the data they need to develop an optimal treatment program for an autistic child.
Recommended: The Afinia L501 Duo Contains The Dye And Pigment Ink Print Heads Along With Both Sets Of Ink Cartridges
Q: What’s the best thing about SpinRise Technologies that people might not know about?
A: My youngest son was diagnosed with autism at a very early age. The original version of our product was just a simple tool that I built to help my son and our family. We presented that tool to the National Science Foundation, and they saw enough potential in it to award our company a Phase 1 SBIR grant. That grant has allowed us to greatly expand the scope of our technology, and we’re looking forward to making those advancements available to the public.
Q: What can we expect from SpinRise Technologies in next 6 months?
A: Within the next few weeks we will be releasing a minimum viable product for iOS, Android, and the web. Concurrently, we are developing the broader technology that we’ve committed to for the NSF. We plan to apply for Phase 2 NSF funding in the near future, and that funding will allow us to bring our entire vision for the product to market.
Q: What do you find most interesting and rewarding in terms of running the company?
A: A child’s autism diagnosis doesn’t just affect that child – it has significant impact on the child’s entire family. Small things like going out to dinner or going out shopping can be difficult or even inconceivable for some families. When our company can help a family successfully navigate these activities that most others take for granted, it’s extremely rewarding.
